GO:0051028 mRNA transport: Genes and Methods

GO:0051028 mRNA transport is a biological process defined by the Gene Ontology as the directed movement of messenger RNA into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This process is fundamental to spatial and temporal control of gene expression, ensuring that transcripts reach the correct subcellular destination for localized translation. In eukaryotic cells, mRNA transport encompasses nuclear export, cytoplasmic trafficking along the cytoskeleton, and delivery to specific compartments such as dendrites, axons, and cell protrusions. The mechanistic coupling between mRNA transport and membrane trafficking has emerged as a central theme, with RNA-binding proteins and motor proteins coordinating cargo selection and movement. For researchers, GO:0051028 provides a framework to annotate and interrogate the machinery that governs RNA localization. Defects in mRNA transport are associated with a broad spectrum of human diseases, including cancer, neurodegeneration, and developmental disorders. Understanding the molecular players and regulatory logic of mRNA transport is therefore essential for functional genomics, drug target discovery, and the design of CRISPR-based disease models. This article synthesizes authoritative QuickGO annotation data and verified PubMed literature to deliver a research-grade overview of mRNA transport, its core components, regulatory mechanisms, disease links, and experimental strategies for CRISPR-based interrogation.

In our own words, GO:0051028 mRNA transport describes the directed, agent-mediated movement of messenger RNA molecules into, out of, or within a cell, or between cells. The process requires molecular agents such as transporters or pores that facilitate the translocation of mRNA cargo. This definition captures both nuclear-cytoplasmic transport and intracellular trafficking events that position mRNAs at specific subcellular locations for localized translation.

mRNA transport is a central determinant of gene expression fidelity, enabling localized translation that supports cell polarity, developmental patterning, and neuronal function. Because mRNA transport is mechanistically coupled to membrane trafficking, it integrates with secretory and endosomal pathways that control cargo delivery and cellular homeostasis. Disruption of mRNA transport machinery has been implicated in cancer, neurodegeneration, and developmental disorders, underscoring its importance as a research and therapeutic target.

The following genes and proteins are core components of mRNA transport machinery, supported by verified literature on RNA localization and membrane trafficking [1,4].

mRNA transport is regulated at multiple levels, including cargo selection by RNA-binding proteins, motor protein activity, and coupling to membrane trafficking pathways. Nuclear export is driven by ATP-dependent DEAD-box helicases that ratchet mRNA out of the nucleus, providing a regulatory checkpoint for export competence. The integration of mRNA transport with membrane trafficking further allows cells to coordinate RNA localization with secretory demand.

Dysregulation of mRNA transport machinery can alter the localization of transcripts encoding oncogenes and tumor suppressors, contributing to cancer progression. RNA-binding proteins involved in transport are frequently misregulated in tumors, making them candidate targets for functional studies.

Neurons depend on mRNA transport to deliver transcripts to dendrites and axons for localized translation. Disruption of this process is linked to neurodegeneration, including conditions where RNA-binding proteins such as FMR1 are affected.

Spatially restricted mRNA localization is essential for developmental patterning, and defects in transport machinery can lead to developmental disorders. Coupling between mRNA transport and membrane trafficking further implicates these pathways in tissue morphogenesis.

Live-cell imaging of tagged mRNAs and RNA-binding proteins allows direct visualization of transport granules and their movement along cytoskeletal tracks. This approach is essential for defining the spatial and temporal dynamics of mRNA transport.

RNA-seq can quantify transcript abundance and identify mRNAs whose localization or stability depends on transport machinery. It is widely used to profile changes following perturbation of transport genes.

Affinity purification and mass spectrometry can identify protein components of mRNA transport granules and their interaction partners. This helps define the molecular composition of transport machinery.

CRISPR knockout and library screening enable systematic testing of genes required for mRNA transport and localization. These methods link genotype to transport phenotypes in disease-relevant cell models.

Researchers studying mRNA transport-related genes often need to determine whether a candidate gene is causally involved in RNA localization, nuclear export, or localized translation. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions.

GO:0051028 mRNA transport is a fundamental biological process that governs the directed movement of mRNA within and between cells, integrating with membrane trafficking and localized translation. Its core machinery, including DEAD-box helicases and RNA-binding proteins, is essential for nuclear export and cytoplasmic trafficking. Dysregulation of mRNA transport is linked to cancer, neurodegeneration, and developmental disorders, making it a high-value area for functional genomics. CRISPR-based models and screening approaches provide powerful tools to dissect the causal roles of transport genes and to accelerate therapeutic discovery.